These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 37089915)

  • 1. Vitamin C and vitamin D
    Chen Q; Zhao L; Mei L; Zhao X; Han P; Liu J; Meng C; Li R; Zhong R; Wang K; Li J
    Front Pharmacol; 2023; 14():1163694. PubMed ID: 37089915
    [No Abstract]   [Full Text] [Related]  

  • 2. Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis.
    Rao Y; Kuang Z; Li C; Guo S; Xu Y; Zhao D; Hu Y; Song B; Jiang Z; Ge Z; Liu X; Li C; Chen S; Ye J; Huang Z; Lu Y
    Gut Microbes; 2021; 13(1):1-19. PubMed ID: 34030573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
    Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
    J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin.
    Xu H; Yuan M; Niu K; Yang W; Jiang M; Zhang L; Zhou J
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuciferine Protects Against High-Fat Diet-Induced Hepatic Steatosis
    Sun J; Fan J; Li T; Yan X; Jiang Y
    J Agric Food Chem; 2022 Sep; 70(38):12014-12028. PubMed ID: 36106619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism.
    Zhang L; Xie C; Nichols RG; Chan SH; Jiang C; Hao R; Smith PB; Cai J; Simons MN; Hatzakis E; Maranas CD; Gonzalez FJ; Patterson AD
    mSystems; 2016; 1(5):. PubMed ID: 27822554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters.
    Sun L; Pang Y; Wang X; Wu Q; Liu H; Liu B; Liu G; Ye M; Kong W; Jiang C
    Acta Pharm Sin B; 2019 Jul; 9(4):702-710. PubMed ID: 31384531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an
    Carbajo-Pescador S; Porras D; García-Mediavilla MV; Martínez-Flórez S; Juarez-Fernández M; Cuevas MJ; Mauriz JL; González-Gallego J; Nistal E; Sánchez-Campos S
    Dis Model Mech; 2019 Apr; 12(5):. PubMed ID: 30971408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
    Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
    Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mining Gut Microbiota From Bariatric Surgery for MAFLD.
    Wu WK; Chen YH; Lee PC; Yang PJ; Chang CC; Liu KL; Hsu CC; Huang CC; Chuang HL; Sheen LY; Liu CJ; Wu MS
    Front Endocrinol (Lausanne); 2021; 12():612946. PubMed ID: 33897617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effect of vitamin C and vitamin D
    Qiu F; Zhang Z; Yang L; Li R; Ma Y
    Nutr Metab (Lond); 2021 May; 18(1):49. PubMed ID: 33964955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism.
    Cornejo-Pareja I; Amiar MR; Ocaña-Wilhelmi L; Soler-Humanes R; Arranz-Salas I; Garrido-Sánchez L; Gutiérrez-Repiso C; Tinahones FJ
    J Gastroenterol; 2024 Apr; 59(4):329-341. PubMed ID: 38265508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis.
    Li H; Xi Y; Xin X; Tian H; Hu Y
    Biomed Pharmacother; 2020 Apr; 124():109915. PubMed ID: 31986416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akkermansia muciniphila alleviates high-fat-diet-related metabolic-associated fatty liver disease by modulating gut microbiota and bile acids.
    Wu W; Kaicen W; Bian X; Yang L; Ding S; Li Y; Li S; Zhuge A; Li L
    Microb Biotechnol; 2023 Oct; 16(10):1924-1939. PubMed ID: 37377410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by
    Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X
    Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polysaccharide-rich fractions from Enteromorpha prolifera improve hepatic steatosis and gut barrier integrity in high-fat diet-induced obese mice linking to modulation of gut microbiota.
    Zou T; Xie F; Liang P; Chen J; Wang Z; Du M; You J
    Biomed Pharmacother; 2023 Jan; 157():114034. PubMed ID: 36434956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intragastric Safflower Yellow Alleviates HFD Induced Metabolic Dysfunction-Associated Fatty Liver Disease in Mice through Regulating Gut Microbiota and Liver Endoplasmic Reticulum Stress.
    Hu W; Lyu X; Xu H; Guo X; Zhu H; Pan H; Wang L; Yang H; Gong F
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of branched-chain amino acids ameliorates high-fat diet-induced metabolic-associated fatty liver disease
    Zhang R; Mu H; Li Z; Zeng J; Zhou Q; Li H; Wang S; Li X; Zhao X; Sun L; Chen W; Dong J; Yang R
    Front Microbiol; 2022; 13():920277. PubMed ID: 35935188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.